what about iressa? of course that didn't ultimately turn out well and may have been the spark for more stringent approval criteria i do know that for melanoma PFS is an approvable endpoint according to the FDA (and pazdur) from the genasense minutes whether or not other surrogates in other indications are approvable is another story